Screening and Management of High-risk Populations of Stroke in Dehui City
SAMHPSDC
1 other identifier
observational
4,100
1 country
1
Brief Summary
This epidemiological survey is to analyze the prevalence rate of stroke and exposure rate of risk factors in sampling population aged 40 years and over (born before December 31,1975) in Dehui City, to provide scientific basis for pertinent prevention and control of stroke in Jilin Province, and to provide valuable data for the high-risk groups to carry out regular follow-up and standardized management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2017
CompletedFirst Submitted
Initial submission to the registry
August 30, 2021
CompletedFirst Posted
Study publicly available on registry
September 9, 2021
CompletedSeptember 9, 2021
August 1, 2021
3 months
August 30, 2021
August 31, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Prevalence rate of stroke
The proportion of stroke in the general population.
4 months
Prevalence rate of hypertension
The proportion of hypertension in the general population.
4 months
Prevalence rate of diabetes mellitus
The proportion of diabetes mellitus in the general population.
4 months
Prevalence rate of dyslipidemia
The proportion of dyslipidemia in the general population.
4 months
Study Arms (3)
Low-risk Group
Low-risk Group is defined as the population with \<3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), but without chronic disease (hypertension, diabetic mellitus, atrial fibrillation or valvular heart disease).
Mediate-risk Group
Mediate-risk Group is defined as the population with \<3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), but meanwhile suffer from chronic disease (hypertension, diabetic mellitus, atrial fibrillation or valvular heart disease).
High-risk Group
High-risk Group is defined as the population with ≥3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), or population with history of stroke or/and transient ischemic attack.
Interventions
Eligibility Criteria
Target population aged 40 years and over (born before December 31,1975) was selected from Dehui City by means of group sampling.
You may qualify if:
- Aged 40 years and over in Dehui City
- Willing to participate in the study and follow-up visits
- Signed an informed consent
You may not qualify if:
- Life expectancy\<3 years
- Unwilling to participate in the study and follow-up visits
- Living away from Dehui City over 6 months
- Unable to cooperate with examination and questionnaire due to mental disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yi Yanglead
- Dehui People's Hospitalcollaborator
Study Sites (1)
First Hospital of Jilin University
Changchun, Jilin, 130000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Yi Yang, M.D. Ph.D.
The First Hospital of Jilin University
- STUDY DIRECTOR
Ying-Qi Xing, M.D. Ph.D.
The First Hospital of Jilin University
- STUDY DIRECTOR
Zhen-Ni Guo, M.D.
The First Hospital of Jilin University
- PRINCIPAL INVESTIGATOR
Fu-Liang Zhang, M.D.
The First Hospital of Jilin University
- PRINCIPAL INVESTIGATOR
Hao-Yuan Liu, M.D.
The First Hospital of Jilin University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Associated Dean of First Hospital of Jilin University
Study Record Dates
First Submitted
August 30, 2021
First Posted
September 9, 2021
Study Start
January 1, 2016
Primary Completion
March 31, 2016
Study Completion
March 31, 2017
Last Updated
September 9, 2021
Record last verified: 2021-08